Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Expert Opinion on Investigational Drugs
|
May 27, 2025
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review
Darren Pan, Anupama Kumar, Jodi J Lipof, et al.
Bone Marrow Transplantation
|
July 31, 2024
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma
Zachary M Avigan, Suzanne Arinsburg, Darren Pan, et al.
Bone Marrow Transplantation
|
October 18, 2024
Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma
Zachary M Avigan, Suzanne Arinsburg, Darren Pan, et al.
Heart & Lung : the Journal of Critical Care
|
June 5, 2021
Pre-hospital antiplatelet medication use on COVID-19 disease severity
Darren Pan, Ada Ip, Serena Zhan, et al.
Blood Advances
|
October 9, 2024
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival
Zachary M Avigan, Saoirse Bodnar, Darren Pan, et al.
Bone Marrow Transplantation
|
May 3, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma
Darren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
Cancer Medicine
|
December 18, 2021
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma
Darren Pan, Jonathan L Kaufman, Myo Htut, et al.
Bone Marrow Transplantation
|
March 30, 2026
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma
Darren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
American Journal of Hematology
|
April 21, 2026
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference
Ajai Chari, Caitlin Costello, Amrita Krishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2025
Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy
Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Expert Opinion on Investigational Drugs
|
May 27, 2025
Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review
Darren Pan, Anupama Kumar, Jodi J Lipof, et al.
Bone Marrow Transplantation
|
July 31, 2024
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma
Zachary M Avigan, Suzanne Arinsburg, Darren Pan, et al.
Bone Marrow Transplantation
|
October 18, 2024
Author Correction: Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma
Zachary M Avigan, Suzanne Arinsburg, Darren Pan, et al.
Heart & Lung : the Journal of Critical Care
|
June 5, 2021
Pre-hospital antiplatelet medication use on COVID-19 disease severity
Darren Pan, Ada Ip, Serena Zhan, et al.
Blood Advances
|
October 9, 2024
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival
Zachary M Avigan, Saoirse Bodnar, Darren Pan, et al.
Bone Marrow Transplantation
|
May 3, 2025
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma
Darren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
Cancer Medicine
|
December 18, 2021
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma
Darren Pan, Jonathan L Kaufman, Myo Htut, et al.
Bone Marrow Transplantation
|
March 30, 2026
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma
Darren Pan, Tarek H Mouhieddine, Tianxiang Sheng, et al.
American Journal of Hematology
|
April 21, 2026
Integrating Recent Evidence and Expert Perspectives Into the Management of Multiple Myeloma: Consensus Recommendations From the 2025 Bridging the Gaps Conference
Ajai Chari, Caitlin Costello, Amrita Krishnan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2025
Clonal hematopoiesis and inflammation predict hematologic toxicity and secondary myeloid malignancies after BCMA-directed chimeric antigen receptor T cell therapy
Zachary M Avigan, Jerrel Catlett, Saoirse Bodnar, et al.
Page
of 3